Pharma
Johnson & Johnson reports mixed Q3 earnings
The company’s pharmaceutical segment performed well, while medtech suffered.
Pharma
Latest news and analysis on pharma from Healthcare Brew, covering the key trends and regulatory shifts impacting the industry.
Pharma
What Eli Lilly’s psychedelic investment could mean for the emerging field
The move may be a sign that Big Pharma companies are becoming more comfortable with the once-stigmatized field.
Pharma
Comprehensive cancer centers are running low on supplies of critical treatments
That could lead to downstream consequences for medical research, one expert says.
Pharma
Novo Nordisk announces rebrand amid competition with Eli Lilly
The two pharma giants are in competition for dominance in the obesity and diabetes markets.
Pharma
Oncologists say newly approved pancreatic cancer drug is a breakthrough for treatment
The medicine doubled survival time for patients in a Phase 3 clinical trial.
Pharma
Moderna and Merck’s positive preliminary cancer vaccine results could signal a ‘new era’ of cancer treatment, expert says
The companies say the treatment slowed melanoma recurrence and spread in the trial.
Pharma
Novo and Lilly race to bring next-generation GLP-1s to market
The drugmakers are looking for ways to make the medicines more effective, and to expand their reach beyond weight loss and diabetes.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
